Valuation: DMS

Market Cap 22.86M 25.54M 21.31M 19.33M 36.46M 2.44B 36.69M 256M 100M 1.26B 95.94M 93.81M 4.05B P/E 2026 *
29.5x
P/E 2027 * 8.84x
Enterprise Value 38.26M 42.74M 35.67M 32.35M 61.02M 4.09B 61.4M 429M 168M 2.11B 161M 157M 6.79B EV / Sales 2026 *
0.67x
EV / Sales 2027 * 0.47x
Free-Float
69.9%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 53 17/07/2022
Director of Finance/CFO - 31/12/2021
Chief Tech/Sci/R&D Officer - 31/12/2018
Director TitleAgeSince
Director/Board Member 56 -
Chairman 53 17/07/2022
Director/Board Member 52 15/06/2025
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 26.06M
+0.64%-2.15%+26.19%+37.23% 243B
+0.63%-0.00%+9.26%+5.59% 155B
+0.87%+5.21%-0.45%+60.69% 150B
+2.60%+3.40%-54.05%-9.87% 61.93B
+1.38%-0.96%+16.84%+23.56% 49.12B
+1.25%+5.82%-16.06%-17.42% 48.78B
+0.46%+0.02%+25.41%+57.27% 48.08B
-0.09%+4.37%+3.23%+36.99% 47.95B
-0.38%-1.82%+30.54%+72.15% 42.62B
Average +0.74%+3.03%+4.54%+29.58% 94.01B
Weighted average by Cap. +0.80%+2.69%+8.40%+31.10%

Financials

2026 *2027 *
Net sales 56.8M 63.45M 52.95M 48.03M 90.58M 6.07B 91.15M 636M 249M 3.13B 238M 233M 10.07B 65.9M 73.61M 61.43M 55.72M 105M 7.04B 106M 738M 289M 3.63B 277M 270M 11.69B
Net income 800K 894K 746K 676K 1.28M 85.43M 1.28M 8.96M 3.51M 44.08M 3.36M 3.28M 142M 2.6M 2.9M 2.42M 2.2M 4.15M 278M 4.17M 29.13M 11.4M 143M 10.91M 10.67M 461M
Net Debt 15.4M 17.2M 14.36M 13.02M 24.56M 1.64B 24.71M 173M 67.54M 849M 64.62M 63.19M 2.73B 8M 8.94M 7.46M 6.76M 12.76M 854M 12.84M 89.62M 35.08M 441M 33.57M 32.83M 1.42B
Logo DMS
Diagnostic Medical Systems (DMS) is France's leader in the development, design, and production of imaging systems for digital and conventional radiology and osteodensitometry. The group's activity is organized around two sectors: - radiology equipment and osteodensitometers sales: mobile radiology units, floating table tops, operating room mobile amplifiers, ultrasound osteodensitometers (designed to chart the bone micro-architecture) and X ray osteodensitometers (designed to measure bone density), etc. The group also proposes devices distribution and maintenance activities; - development of biotechnology solutions: in the fields of arthrosis treatment and regenerative medicine. Products and services are marketed primarily by exclusive retailers. Net sales (not including sold divisions) are distributed geographically as follows: Europe (49.6%), North and South America (17%), Asia (7.5%), Middle East (7.5%), Africa (3.1%), Oceania (1%) and other (14.3%).
Employees
-
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Ratings Surperformance© - DMS